Status:
COMPLETED
Defining Optimal Settings for Transbronchial Lung Cryobiopsy II: An Ex-Vivo Human Lungs Model Study for Improvement of Specimen Quality
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Conditions:
Transbronchial Lung Cryobiopsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Diffuse parenchymal lung disease (DPLD) or Interstitial Lung Disease (ILD) comprises a broad variety of lung pathologies in which accurate diagnosis is crucial given to the different prognosis and the...
Detailed Description
Transbronchial lung cryobiopsy (TBLC) is a less invasive procedure than surgical lung biopsy (SLB) to establish the diagnosis of interstitial lung disease (ILD) and as an endoscopic intervention can b...
Eligibility Criteria
Inclusion
- Lungs from patients undergoing lung transplantation after their removal from the recipient patient with previous informed consent signed before transplantation.
Exclusion
- Patients not candidates for surgical removal of the lungs during the act of transplantation.
Key Trial Info
Start Date :
March 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 17 2021
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04285463
Start Date
March 4 2020
End Date
July 17 2021
Last Update
March 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHUM
Montreal, Quéebec, Canada